feed,title,long_url,short_url
SeekingAlpha,Dicerna concludes enrollment in mid-stage nedosiran trial in rare metabolic disorder,https://seekingalpha.com/news/3648354,
SeekingAlpha,On the hour,https://seekingalpha.com/news/3648364,
